GlobeNewswire

SolarWinds Extends Network Management Software Leadership with Deeper Visibility and Smarter Scalability

Dela

Software now simplifies management of complex networks with Network Insight for Cisco Nexus and intelligent mapping, supporting environments four times larger than previous generation

AUSTIN, Texas, May 23, 2018 (GLOBE NEWSWIRE) -- SolarWinds, the worldwide leader in network management software, today announced a wave of updates to its network management product portfolio, which can now support networks up to four times larger than the previous generation. This significant gain makes it easy to consolidate monitoring solutions to a single provider enterprise-wise, and gives IT professionals far greater flexibility to scale up and support larger data center networks as workloads increase, or scale out to address complex distributed networks. 

SolarWinds says the broad refresh of its network management portfolio strengthens its IDC®-validated network management leadership position.1 Updated versions of Network Performance Monitor (NPM), Network Configuration Manager (NCM), IP Address Manager (IPAM), NetFlow Traffic Analyzer (NTA), and VoIP & Network Quality Manager (VNQM) are now available.

"In the hybrid IT world, networks are growing larger, more complex, and more distributed, making them even more challenging to manage and troubleshoot," said Christoph Pfister, executive vice president of products, SolarWinds. "This is a big reason why over half of enterprise IT professionals in our SolarWinds 2018 IT Trends Report said they do not feel as confident in their IT environment's performance as their mid-size and small business counterparts."

"By quadrupling scalability and deepening visibility, SolarWinds network management software will give IT professionals unprecedented flexibility to evolve easily as their networks expand and spread out. It also offers the power to manage networks simply, comprehensively, and accurately, all without compromising our industry-leading affordability," he added. "As recently confirmed for the third year in a row, we believe our position as highest in ability to execute in the 2018 Gartner® Magic Quadrant® for Network Performance Monitoring and Diagnostics2 reinforces our commitment to helping organizations meet their network management needs today, regardless of their size."

Navigating the Complexity of Today's Networks

The updated SolarWinds® network management portfolio features three breakthroughs designed to further improve visualization and speed troubleshooting across the complex and distributed networks at the foundation of today's hybrid IT environments. 

  • First, the four-fold increase in monitoring capacity allows IT professionals to accelerate and simplify their network management process while reducing the resources needed for monitoring activities, making it easier to consolidate tools.  
     
  • Second, the latest software adds intelligent, auto-generating, and contextually-aware maps that enable faster and clearer visualization of network performance. These powerful capabilities enable IT professionals to quickly identify issues and speed time-to-resolution when troubleshooting. 
     
  • Third, SolarWinds is introducing Network Insight(TM) for Cisco Nexus®, the latest Network Insight, which already includes support for F5® and Cisco® ASA. Adding support for Cisco Nexus bridges a huge gap in data center performance visibility with in-depth analyses that go beyond basic hardware health and statistics.

    This feature gives IT professionals a quick view of the landscape and any bottlenecks. It presents data in a simplified functional model, so that everyone on the IT staff can achieve expert-level insights on Nexus performance regardless of proficiency level. By embracing Cisco Nexus hardware, this new Network Insight also underscores the SolarWinds commitment to enabling superior device-specific visibility for environments of all sizes.

"The Network Insight for Cisco Nexus feature is doing a lot to help us monitor our environment much more effectively," said Josh Haberman, Network Engineer, Veolia North America, the world's leading provider of environmental solutions. "There really is a need for deeper visibility and this latest offering from SolarWinds clearly shows us what is happening in the network," he added. "The scalability improvements were also an unexpected surprise. It's reassuring to have the extra capacity as we plan for the future."

Further, the enhanced network management portfolio builds on other SolarWinds innovations such as NetPath(TM), which provides a "hop-by-hop" analysis of network performance across hybrid IT landscapes and into the public cloud. Recently, SolarWinds began deployment of NetPath onto its Managed Service Provider (MSP) platforms, providing another way to access this powerful technology regardless of how they monitor their environments. This important migration underscores the ongoing commitment made by a worldwide leader in network monitoring and management to extending the powerful benefits of its technology and expertise beyond its core customer base of IT practitioners and into the growing legions of all professionals who manage IT environments.

New Versions across the Network Management Portfolio

Within its network management portfolio, SolarWinds announced updates to the following software products.

  • Network Performance Monitor (NPM) 12.3 - Along with Network Insight for Cisco Nexus, including detailed visibility into virtual Port Channels (vPCs), the latest version of NPM provides superior network monitoring capabilities and detailed visibility for multi-vendor environments.
     
  • Network Configuration Monitor (NCM) 7.8 - The updated version brings even stronger automation and control of network functions and, like NPM, adds Network Insight for Cisco Nexus switches. It provides configuration snippets and the ability to filter, search, and view access control lists (ACLs), including object groups, and Virtual Device Context (VDC) support. 
     
  • IP Address Manager (IPAM) 4.7 - A valuable tool that automates management of IP addresses, the latest version now automates IP requests and monitors hybrid environments with Amazon® Route53 and Azure® DNS support.
     
  • NetFlow Traffic Analyzer (NTA) 4.4 - With a new Flow Storage SQL database at its foundation and less-demanding CPU and IOPS requirements, the new version offers IT professionals significantly improved speed and performance in identifying network traffic issues and removing bottlenecks, while providing better security.
     
  • VoIP and Network Quality Manager (VNQM) 4.5 - The latest version of VNQM adds support for monitoring of SIP trunks, enabling users to manage voice quality and performance across networks using the latest VoIP technologies.

Pricing and Availability

The updated SolarWinds network management portfolio, including Network Insight for Cisco Nexus, will be available starting on May 30, 2018. SolarWinds NPM pricing starts at $2,955*; SolarWinds NCM pricing starts at $2,895*; SolarWinds IPAM pricing starts at $1,995*; SolarWinds NTA pricing starts at $1,915*; and SolarWinds VNQM pricing starts at $1,615*.

SolarWinds will publicly demonstrate its updated network management portfolio for the first time at Cisco Live!® in Orlando, Fla., starting on June 10. The SolarWinds booth number is 1259.

For more information, visit the SolarWinds website , or call 866.530.8100.

*Prices as of May 30, 2018 in US Dollars. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Connect with SolarWinds

1 Source: IDC-defined Network Management Software functional market. IDC's Worldwide Semiannual Software Tracker®, April 2018

2 Source: Gartner, "Magic Quadrant for Network Performance Monitoring and Diagnostics," Sanjit Ganguli, Vivek Bhalla, Pankaj Prasad, 21 February 2018.

Gartner Disclaimer 
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About SolarWinds

SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as the worldwide leader in both network management software and MSP solutions, and is driving similar growth across the full spectrum of IT management software. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

       
MEDIA CONTACTS:      
Nicole Fachet     Jenne Barbour
Text100     SolarWinds
Phone: 212.871.3950     Phone: 512.498.6804
NicoleF@text100.com     pr@solarwinds.com
       

Photos accompanying this announcement are available at: 

http://www.globenewswire.com/NewsRoom/AttachmentNg/a0ee85af-57cd-4e57-bd2a-4ad2a67e33c9

http://www.globenewswire.com/NewsRoom/AttachmentNg/95179026-6b4d-4b9c-b791-f769421162ff




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum